Second Alzheimer's drug in the pipeline promises to slow worsening but with safety concern

Eli Lilly and Co. is seeking Food and Drug Administration approval of donanemab. If cleared, it would be only the second Alzheimer’s treatment convincingly shown to delay the mind-robbing disease — after the recently approved Leqembi from Japanese drugmaker Eisai.

Image

Image alternative text

MeepMorp, 11 months ago

“Both donanemab and Leqembi are lab-made antibodies, administered by IV, that target one Alzheimer’s culprit, sticky amyloid buildup in the brain. And both drugs come with a serious safety concern — brain swelling or bleeding that in the Lilly study was linked to three deaths.”

reply

report

activity

copy /kbin url

copy original url

Loading...

Federation

Status:

On | Off

Instances:

/m/[email protected]

Threads (5111)

Microblog (4)

People

Magazines

Thread

MicroWave

@[email protected]

Added: 11 months ago
Views: 14
Online: -
Ratio: 0

Magazine

news

@[email protected]

Welcome to the News community!

Rules:

Be civil___ Attack the argument, not the person. No racism/sexism/bigotry. Good faith argumentation only. Trolling is uncivil and is grounds for removal and/or a community ban. ___
All posts should contain a source (url) that is as reliable and unbiased as possible and must only contain one link.___ Obvious right or left wing sources will be removed at the mods discretion. We have an actively updated blocklist, which you can see here: lemmy.world/post/2246130 if you feel like any website is missing, contact the mods. Supporting links can be added in comments or posted seperately but not to the post body. ___
No bots, spam or self-promotion.___ Only approved bots, which follow the guidelines for bots set by the instance, are allowed. ___
Post titles should be the same as the article used as source.___ Posts which titles don’t match the source won’t be removed, but the autoMod will notify you, and if your title misrepresents the original article, the post will be deleted. If the site changed their headline, the bot might still contact you, just ignore it, we won’t delete your post. ___
Only recent news is allowed.___ Posts must be news from the most recent 30 days. ___
All posts must be news articles.___ No opinion pieces, Listicles, editorials or celebrity gossip is allowed. All posts will be judged on a case-by-case basis. ___
No duplicate posts.___ If a source you used was already posted by someone else, the autoMod will leave a message. Please remove your post if the autoMod is correct. If the post that matches your post is very old, we refer you to rule 5. ___
Misinformation is prohibited.___ Misinformation / propaganda is strictly prohibited. Any comment or post containing or linking to misinformation will be removed. If you feel that your post has been removed in error, credible sources must be provided. ___
No link shorteners.___ The auto mod will contact you if a link shortener is detected, please delete your post if they are right. ___
Don't copy entire article in your post body___ For copyright reasons, you are not allowed to copy an entire article into your post body. This is an instance wide rule, that is strictly enforced in this community.

Created: 1 year ago
Owner: barista
Subscribers: 8
Online: -

Moderators

barista

Add comment